Bruderman Asset Management, LLC Gsk PLC Transaction History

Bruderman Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$42.0 - $48.25 $334,530 - $384,311	-7,965 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $26,946 - $28,984	-666 Reduced 7.72%	7,965 $354,000
Q2 2019 Aug 12, 2019	SELL	$39.4 - $42.7 $118,200 - $128,100	-3,000 Reduced 25.79%	8,631 $345,000
Q1 2019 May 14, 2019	SELL	$38.57 - $42.69 $30,624 - $33,895	-794 Reduced 6.39%	11,631 $486,000
Q4 2018 Feb 11, 2019	SELL	$37.8 - $42.69 $104,101 - $117,568	-2,754 Reduced 18.14%	12,425 $475,000
Q3 2018 Nov 09, 2018	SELL	$39.75 - $42.69 $6.16 Million - $6.61 Million	-154,918 Reduced 91.08%	15,179 $610,000
Q2 2018 Aug 15, 2018	SELL	$39.61 - $42.76 $3.56 Million - $3.84 Million	-89,896 Reduced 34.58%	170,097 $6.86 Million
Q1 2018 May 10, 2018	BUY	$36.18 - $40.15 $2.32 Million - $2.58 Million	64,249 Added 32.82%	259,993 $10.2 Million
Q4 2017 Feb 06, 2018	SELL	$35.34 - $41.9 $4.31 Million - $5.11 Million	-121,959 Reduced 38.39%	195,744 $6.94 Million
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $12.5 Million - $13.2 Million	317,703	317,703 $12.9 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Bruderman Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bruderman Asset Management, LLC with notifications on news.